Pharma-Bio Serv (PBSV) Cash & Equivalents Growth (3y) (2013 - 2026)
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 6.00% |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | - |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 8.27% |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 9.45% |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 37.08% |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 1.74% |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 9.08% |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | -6.99% |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 6.17% |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -39.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -39.52% |
| Jan 31, 2026 | -7.26% |
| Oct 31, 2025 | -38.41% |
| Jul 31, 2025 | -34.74% |
| Apr 30, 2025 | -45.82% |
| Jan 31, 2025 | -21.92% |
| Oct 31, 2024 | -27.10% |
| Jul 31, 2024 | -26.61% |
| Apr 30, 2024 | -39.78% |
| Jan 31, 2024 | -30.36% |
| Oct 31, 2023 | -15.21% |
| Jul 31, 2023 | -44.53% |
| Apr 30, 2023 | -19.61% |
| Jan 31, 2023 | -22.05% |
| Oct 31, 2022 | -2.26% |
| Jul 31, 2022 | -1.27% |
| Apr 30, 2022 | -5.16% |
| Jan 31, 2022 | -0.95% |
| Oct 31, 2021 | 2.91% |
| Jul 31, 2021 | 2.95% |